HAE:NYSE
Haemonetics Corp
$104.68
0.00%
(0.00) 1D
$104.68
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 5, 4:00:04 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HAE...
Open
$104.29
High
$106.26
Low
$103.64
Mkt. cap
4.76B
Avg. vol.
573.32K
Volume
576.14K
P/E ratio
51.06
52-wk high
$110.45
52-wk low
$48.17
EPS
$2.05
Beta
0.61
Shares outstanding
45.50M
No. of employees
3K
Open
$104.29
High
$106.26
Low
$103.64
Mkt. cap
4.76B
Avg. vol.
573.32K
Volume
576.14K
P/E ratio
51.06
52-wk high
$110.45
52-wk low
$48.17
EPS
$2.05
Beta
0.61
Shares outstanding
45.50M
No. of employees
3K
News stories
From web sources and news partners
Zacks
·
4 hours ago
PAHC vs. HAE: Which Stock Is the Better Value Option?
Benzinga
·
9 hours ago
Haemonetics Q1 2027 Earnings Call Transcript
AD HOC NEWS
·
11 hours ago
Haemonetics stock heads into November 5 results with key benchmarks
AD HOC NEWS
·
1 day ago
Haemonetics stock heads into November 5 results after earnings beat
Profile
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen Latham in the 1970s.
Today, the company has expanded and has offices located in 16 countries. The company employs more than 1,800 people and markets its products in over 50 countries. Revenue is derived nearly equally from its three major markets -- Asia, Europe, and the Americas. Wikipedia
About Haemonetics Corp
CEOChristopher Simon
Employees3.01K
Founded1971
HeadquartersBoston, Massachusetts, United States
SectorMedical device
Websitehaemonetics.com